OBO ID: CHEBI:15551
Term Name: prostaglandin E2 Search Ontology:
Synonyms:
  • (15S)-prostaglandin E2
  • (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
  • (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate
  • (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate
  • (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
  • (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid
  • (Z)-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid
  • Dinoproston
  • dinoprostona
  • Dinoprostone
  • dinoprostonum
  • PGE2
  • Prepidil
  • Propess
  • Prostaglandin E2
  • Prostin E2
Definition: Prostaglandin F2alpha in which the hydroxy group at position 9 has been oxidised to the corresponding ketone. Prostaglandin E2 is the most common and most biologically potent of mammalian prostaglandins.
References:
  • Beilstein:2224724
  • CAS:363-24-6
  • DrugBank:DB00917
  • Drug_Central:913
  • HMDB:HMDB0001220
  • KEGG:C00584
  • KEGG:D00079
  • LIPID_MAPS_instance:LMFA03010003
  • MetaCyc:5Z13E-15S-1115-DIHYDROXY-9-OXOPROS
  • PMID:24501112
  • PMID:7224729
  • PMID:7836930
  • Patent:DE2011969
  • Patent:GB851827
  • Patent:NL6505799
  • Patent:US3598858
  • Reaxys:2224724
  • Wikipedia:Prostaglandin_E2
Ontology: Chebi
PHENOTYPE No data available